A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma

Annals of Oncology

Volumn 12, Issue 4, 2001, Pages 541-547

  Duenas Gonzalez A ^a,b   Lopez Graniel, C ^a   Gonzalez, A ^a   Reyes, M ^a   Mota, A ^a   Munoz D ^a   Solorza, G ^a   Hinojosa, L M ^a   Guadarrama, R ^a   Florentino, R ^a   Mohar, A ^a,b   Meléndez Zagla, Jorge ^a   Maldonado, V ^a   Chanona, J ^a   Robles, E ^a   De La Garza, J ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cervical cancer; Gemcitabine cisplatin; Neoadjuvant chemotherapy

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ANTIEMETIC AGENT; BLEOMYCIN; CISPLATIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; GRANISETRON; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; MITOMYCIN C; NAVELBINE; PACLITAXEL; SODIUM CHLORIDE; STEROID; VINBLASTINE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ALLERGY; ALOPECIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLEEDING; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG FEVER; DRUG RESPONSE; EVALUATION; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; GRANULOCYTOPENIA; HEMATURIA; HISTOPATHOLOGY; HUMAN; INFECTION; NEUROPATHY; PATIENT CARE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; SKIN TOXICITY; STANDARD; TOXICITY; UROGENITAL SYSTEM; UTERINE CERVIX CARCINOMA;

EID: 17344390754     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011117617514     Document Type: Article

References (46)

1. Whelan SL, Parkin DM, Masuyer E. Patterns of Cancer in Five Continents. Lyon: International Agency for Research on Cancer 1990.
2. Omura GA. Chemotherapy for stage IVB or recurrent cancer of the uterine cervix. Monogr NCI 19996; 21: 123-6.
3. Peters WA 3rd, Liu PY, Barrett R et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606-13.
4. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137-43.
5. Keys HM, Bundy BN, Stehman FB et al. A comparison of weekly cisplatin during radiation therapy versus irradiation alone each followed by adjuvant hysterectomy in bulky stage IB cervical carcinoma: A randomized trial of the Gynecology Oncology Group. N Engl J Med 1999; 340: 1154-61.
6. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based chemoradiation improves progression-free survival in advanced cervical cancer: Results of a randomized Gynecologic Oncology Group study. N Engl J Med 1999; 340: 1144-53.
7. Whitney CW, Sause W, Bundy BN et al. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages UB IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group Study. J Clin Oncol 1999; 17: 1339-48.
8. Chauvergne J, Rohart J, Heron JF et al. Randomized phase III trial of neoadjuvant chemotherapy and radiotherapy vs. radiotherapy in stage IIB, III caracinoma of the cervix: A cooperative study of the French Oncology Centers. Procc Am Soc Clin Oncol 1988; 7: 136.
9. Tattersall MH, Ramirez C, Coppleson M. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer. Int J Gynecol Oncol 1992; 2: 244-51.
10. Kumar L, Kaushal R, Nandy M et al. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: A randomized study. Gynecol Oncol 1994; 54: 307-15.
11. Souhami L, Gil RA, Allan SE et al. A randomized trial of chemotherapy followed by pelvic radiotherapy in stage IIIB carcinoma of the cervix. J Clin Oncol 1991; 9: 970-7.
12. Tattersall MNH, Lorvidhaya V, Vootiprux et al. A randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol 1995; 13: 444-51.
13. Serur E, Mathews RP, Gates J et al. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix. Gynecol Oncol 1997; 65: 348-56.
14. Namkoong SE, Park JS, Kim JW et al. Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without perioperative adjuvant chemotherapy. Gynecol Oncol 1995; 59: 136-42.
15. Meden H, Fattahi-Meibodi A, Osmers R et al. Wertheim's hysterectomy after neoadjuvant carboplatin-based chemotherapy in patients with cervical cancer stage IIB and IIIB. Anticancer Res 1998; 18: 4575-9.
16. Giardina G, Riochhiardi G, Danese S et al. Weekly cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer: A well-tolerated alternative. Eur J Gynecol Oncol 1997; 18: 173-6.
17. Leone B, Vallejo C, Perez J et al. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma. Am J Clin Oncol 1996; 19: 132-5.
18. Sardi J, Giaroli A, Sananes C et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: The final results. Gynecol Oncol 1997;67:61-9.
19. Chang TC, Lai CH, Hong JH et al. Randomized trial of neoadjuvant cisplatin, vineristine, bleomycin and radical hysterectomy versus radiation therapy for bulky IB and IIA cervical cancer. J Clin Oncol 2000; 18: 1740-7.
20. Benedetti-Panici P, Landoni F, Greggi S et al. Neoadjuvant chemotherapy and radical surgery vs. exclusive radiotherapy in locally advanced squamous cell cervical cancer. Results from the Ilalian Multicenter Randomized Trial. Proc Am Soc Clin Oncol 1999; 18: 357a.
21. Sardi J, Giaroli A, Sananes C et al. Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma of the cervix uteri: An unexpected therapeutic management, Int J Gynecol Cancer 1996; 6: 85-93.
22. Carmichael J. The role of gemcitabine in the treatment of other tumours. Br J Cancer 1998; 78 (Suppl 3): 7821-5.
23. Hui YF, Reitz J, Gemcitabine. A cytidine analogue active against solid tumors. Am J Health-Syst Pharm 1997; 54: 162-70.
24. Lawrence TS, Eisbruch A, McGinn CJ et al. Radiosensitization by gemcitabine. Oncology (Huntingt) 1999; 13 (10, Suppl 5): 1355-60.
25. Van Moorsel CJ, Veerman G, Bergman AM et al. Combination chemotherapy studies with gemcitabine. Semin Oncol 1997; 24 (2. Suppl 7): 17-23.
26. Kanzawa F, Saijo N. In vitro interaction between gemcitabine and other anticancer drugs using a novel three-dimensional model. Semin Oncol 1997; 24 (2, Suppl 7): 8-16.
27. Sandler AB, Nemunaitis J, Denham C et al. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2000; 18: 122-30.
28. von der Maase H, Andersen L, Crino L et al. Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial. Ann Oncol 1999; 10: 1461-5.
29. Hitt R, Castellano D, Hidalgo M et al. Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck. Ann Oncol 1998; 9: 1347-9.
30. Burnett AF, Roman LD, Garcia AA et al. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 2000; 76: 63-6.
31. Miller AB, Hoogstraten B, Staquet M et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
32. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
33. Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989; 10: 1-10.
34. Eddy GL. Neoadjuvant chemotherapy before surgery in cervical cancer. Monogr NCI 1996; 21: 93-6.
35. Sugiyama T, Nishida T, Kumagai S et al. Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. Br J Cancer 1999; 81: 95-8.
36. Pignata S, Silvestro G, Ferrari E et al. Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix. J Clin Oncol 1999; 17: 756-60.
37. Zanetta G, Lissoni A, Pellegrino A et al. Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer. Ann Oncol 1998; 9: 977-80.
38. Peters GJ, Bergman AM, Ruiz van Haperen VW et al. Interaction between cisplatin and gemcitabine in vitro and in vivo. Semin Oncol 1995; 22 (4, Suppl 11): 72-9.
39. Peters GJ, Ruiz van Haperen VW, Vergman AM et al. Preclinical combination therapy with gemcitabine and mechanisms of resistance. Semin Oncol 1996; 23 (5, Suppl 10): 16-24.
40. Goedhals L, Bezwoda WR. A phase II study of gemcitabine in advanced cervix carcinoma: Final data. Procc Am Soc Clin Oncol 1996; 15: 296.
41. Fukuoka M, Noda K, Hasegawa K et al. An early phase II study of gemcitabine hydrochloride LY 188011. Gemcitabine Cooperative Study Group for Early Phase II. Gan To Kagaku Ryoho 1996; 23: 1813-24.
42. Schilder RJ, Blessing JA, Morgan M et al. Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: A phase II study of the gynecologic oncology group. Gynecol Oncol 2000; 76: 204-7.
43. Dueñas-Gonzalez A, Hinojosa-Garcia LM, Lopez-Graniel C et al. Weekly cisplatin/low-dose gemcitabine for advanced and recurrent cervical carcinoma. Am J Clin Oncol (in press).
44. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 1975; 46: 507-10.
45. Van Nagel JR Jr, Donaldson ES, Parker JC et al. The prognostic significance of cell type and lesion size in patients with cervical cancer treated by radical surgery. Gynecol Oncol 1977; 5: 141-51.
46. Fuller AFJr, Elliott N, Kosloff C et al. Lymph node metastases from carcinoma of the cervix stages IB and IIA: Implications for prognosis and treatment. Gynecol Oncol 1982; 13: 165-74.